SCHEMBL14066871

SCHEMBL14066871

c1ccc(N(c2ccccc2)c2ccc(-c3cc4c5ccccc5c5cc(-c6ccc(N(c7ccccc7)c7ccccc7)cc6)c6ccccc6c5c4c4ccccc34)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
MAPT P10636 3/20 0.41
KDM4E B2RXH2 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
ATM Q13315 2/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
TLR9 Q9NR96 1/20 0.35
HPGD P15428 3/20 0.34
MPI P34949 1/20 0.34
APP P05067 2/20 0.34
MAPK1 P28482 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9889162 0.96 ALDH1A1 (0.41) ALDH1A1L3MBTL1MAPTKDM4ETDP1
SCHEMBL1753730 0.90 ALDH1A1 (0.45) ALDH1A1L3MBTL1MAPTKDM4ETDP1
SCHEMBL4545236 0.90 ALDH1A1 (0.45) ALDH1A1L3MBTL1MAPTKDM4ETDP1
SCHEMBL9971761 0.90 ALDH1A1 (0.45) ALDH1A1L3MBTL1MAPTKDM4ETDP1
SCHEMBL14328237 0.89 ALDH1A1 (0.35) ALDH1A1L3MBTL1MAPTKDM4ETDP1
SCHEMBL13615836 0.85 ALDH1A1 (0.41) ALDH1A1L3MBTL1MAPTKDM4ETDP1
SCHEMBL13408760 0.85 ALDH1A1 (0.41) ALDH1A1L3MBTL1MAPTKDM4ETDP1
SCHEMBL14066893 0.85 ALDH1A1 (0.35) ALDH1A1L3MBTL1MAPTKDM4ETDP1
SCHEMBL12433936 0.85 ALDH1A1 (0.43) ALDH1A1L3MBTL1MAPTKDM4ETDP1
SCHEMBL14066932 0.85 MAOA (0.37) ALDH1A1L3MBTL1MAPTKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080226940-A1 DIBENZO[C,G]TRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2008-09-18 US disclosed
US-20080226940-A1 DIBENZO[C,G]TRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2008-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080226940-A1 DIBENZO[C,G]TRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME JUP, EED, L1CAM ALDH1A1 954/4885L3MBTL1 39/4885MAPT 3382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.